Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) has a beta of 0.66. The stock’s Relative Strength Index (RSI) is 41.19, with weekly volatility at 5.81% and ATR
Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) shares traded lower over the last trading session, losing 0.00% on 06/09/21. The shares fell to a low of $1.50
Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) shares traded lower over the last trading session, losing -2.50% on 05/27/21. The shares fell to a low of $1.553
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
